EAU guidelines on renal cell carcinoma: the 2010 update | European Urology | 2010 | 1K |
EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction | European Urology | 2013 | 808 |
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update | European Urology | 2019 | 597 |
EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction | European Urology | 2015 | 541 |
Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines | European Urology | 2011 | 465 |
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study | Nature Genetics | 2009 | 360 |
Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy | European Urology | 2016 | 276 |
The updated EAU guidelines on muscle-invasive and metastatic bladder cancer | European Urology | 2009 | 260 |
Anatomy, physiology, and pathophysiology of erectile dysfunction | Journal of Sexual Medicine | 2010 | 242 |
CXCR4/CXCL12 expression and signalling in kidney cancer | British Journal of Cancer | 2002 | 218 |
Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial | European Urology | 2012 | 200 |
Specific chromosome aberration in human renal cell carcinoma | International Journal of Cancer | 1987 | 181 |
CHARACTERIZATION AND FUNCTIONAL RELEVANCE OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ISOENZYMES OF THE HUMAN PROSTATE | Journal of Urology | 2001 | 163 |
Impact of gender on bladder cancer incidence, staging, and prognosis | World Journal of Urology | 2011 | 154 |
Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients | European Journal of Nuclear Medicine and Molecular Imaging | 2003 | 146 |
The current status of robotic pelvic surgery: results of a multinational interdisciplinary consensus conference | Surgical Endoscopy and Other Interventional Techniques | 2009 | 145 |
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis | BJU International | 2015 | 141 |
Endoscopic extraperitoneal radical prostatectomy: oncological and functional results after 700 procedures | Journal of Urology | 2005 | 136 |
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma | European Urology | 2019 | 125 |
Tissue-specific expression of a constitutional 3;6 translocation: development of multiple bilateral renal-cell carcinomas | International Journal of Cancer | 1989 | 125 |
Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction | World Journal of Urology | 2010 | 122 |
The Role of CD44 in Disease Pathophysiology and Targeted Treatment | Frontiers in Immunology | 2015 | 119 |
Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group | World Journal of Urology | 1997 | 118 |
Detrusor underactivity: a plea for new approaches to a common bladder dysfunction | Neurourology and Urodynamics | 2011 | 114 |
Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue | Urology | 2000 | 109 |